Early detection of liver cancer: Diagnosis and management

Michael L. Volk, Jorge A. Marrero

Research output: Contribution to journalArticlepeer-review

23 Scopus citations


Hepatocellular carcinoma (HCC) is the fifth most common cause of cancer deaths worldwide, and the incidence is rising. Despite a wide array of treatment options, fewer than half of candidates for potentially curative treatments receive them. The diagnosis and management of HCC require a multidisciplinary approach involving various clinical specialties. The foundation of diagnosis is high-quality imaging, with MRI being the test of choice. Some patients also require guided biopsy when MRI is equivocal. Treatment options depend upon the tumor stage and the degree of underlying synthetic dysfunction. Potentially curative treatments include surgical resection and transplantation. Other treatments that prolong survival include percutaneous ablation and transarterial chemoembolization. A new oral agent, sorafenib, was recently shown to prolong survival in patients with advanced HCC. By increasing surveillance and treatment of HCC, outcomes for these patients may be improved.

Original languageEnglish (US)
Pages (from-to)60-66
Number of pages7
JournalCurrent gastroenterology reports
Issue number1
StatePublished - Dec 1 2008

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Early detection of liver cancer: Diagnosis and management'. Together they form a unique fingerprint.

Cite this